BRID Bridgford posts 461 percent Q4 2001 EPS miss shares remain unchanged in todays trading Is Linkage LGCB stock a buy today Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation